In New York, genomic data analysis platforms from Seven Bridges and SolveBio have been integrated with each other to provide expanded capabilities to clients. While financial terms of the agreement were not publicly available, Seven Bridges raised $45 million and SolveBio raised $4.5 million in financing earlier this year. The Seven Bridges platform allows the analysis of millions of genomes with other data. Their clients include the Children’s Hospital of Philadelphia, the VA’s Million Veteran Program, and the National Cancer Institute. SolveBio’s platform allows the indexing and linking of biomarkers and variant data. Now with both platforms integrated, clients can analyze large genomic datasets using Seven Bridges and connect that information to SolveBio for interpretation and assessments.
Latest article
Mercedes-Benz taps Modern Meadow for 80% plant-based leather
In Germany, luxury car manufacturer Mercedes-Benz has partnered with New Jersey biodesign firm Moden Meadow to develop a next-generation leather alternative for its CONCEPT...
Bioluminescent dress from van Herpen portends era of living couture
In France, Dutch fashion designer Iris van Herpen has unveiled a dress embedded with 125 million bioluminescent algae at Paris Haute Couture Week 2025....
Stella McCartney’s latest sneaker can be composted, smells of cinnamon
In London, sustainable fashion pioneer Stella McCartney has unveiled a new version of its S-Wave sneakers, featuring soles made entirely from BioCir Flex, a...